ENTITY
Wuxi Biologics

Wuxi Biologics (2269 HK)

706
Analysis
Health Care • China
Wuxi Biologics is a global Contract Research, Development, and Manufacturing Organization (CRDMO) offering end-to-end solutions for biologics discovery, development, and manufacturing, including complex modalities like monoclonal antibodies and antibody-drug conjugates. The company provides comprehensive services from concept to commercialization, including vaccine CRDMO services. It was founded in 2010 and is headquartered in Wuxi, China.
more
Company Event • 24 Mar 2027 20:00 • Upcoming
Add To Calendar

H2 2026

Company Event • 26 Aug 2026 20:00 • Latest

H1 2026

Company Event • 01 Jun 2026 20:00

Investor update

Company Event • 25 Mar 2026 20:00

H2 2025

Company Event • 15 Jan 2026 00:15

44th Annual J.P. Morgan Healthcare Conference

x